IART Q2 2017 Earnings — Integra LifeSciences Holdings Corporation Revenue & Financial Results | Market Cap Arena

IARTIntegra LifeSciences Holdings Corporation

$747M

Q2 2017 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$282M+13.2% YoY

Gross Profit

$183M64.9% margin

Operating Income

$17M6.0% margin

Net Income

$11M3.8% margin

EPS (Diluted)

$0.14

QoQ Revenue Growth

+9.1%

Cash Flow

Operating Cash Flow

$29M

Free Cash Flow

$16M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$2.1B

Total Liabilities

$1.2B

Stockholders' Equity

$895M

Cash & Equivalents

$155M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$282M	$249M	+13.2%
Gross Profit	$183M	$160M	+14.7%
Operating Income	$17M	$22M	-24.1%
Net Income	$11M	$13M	-15.1%

Revenue Segments

Specialty Surgical Solutions

$160M57%

Orthopedics and Tissue Technologies

$122M43%

Geographic Segments

UNITED STATES

$219M78%

Europe

$32M12%

Rest Of World

$30M11%